The serologic diagnosis of syphilis is done with two assays or microhemagglutinin assay for antibody to T. pallidum [MHA-TP] ). Patients with serum reactive to both nontreponeperformed in series. First, serum is screened in a flocculation mal antigens and specific treponemal antigens are considered assay using nontreponemal antigens (cardiolipin, cholesterol, to have current or past syphilis infection. Those with positive and lecithin) to detect antibodies that cross-react with treponescreening tests but nonreactive confirmatory tests and no clinimal cell surface lipids (VDRL and rapid plasma reagin [RPR] cal findings are referred to as ''biologic false-positive'' (BFP) tests) [1] . Serum reactive in this screening assay is then retested reactors and are not considered to have syphilis. bodies to 17F and 47F T. pallidum membrane proteins, suggesting a diagnosis of syphilis prior to its diagnosis by conventional testing. Although sera specimens were selected Results for further study because a high-titer BFP reaction was documented, these antibodies were present even at visits 5 and 6, Of the 1117 study participants, 73% were male, 93% were black, and 77% were HIV seropositive. Eighty percent of the when the RPR was nonreactive. subjects were in the RPR-negative group, 10% were in the BFP reactor group, and 10% were in the syphilis group. There Discussion were no differences between the BFP reactor and the RPRnegative groups with respect to age, crack cocaine use, drug By current treatment guidelines, a person with reactive nontreponemal serology and nonreactive treponemal serology use pattern, or sex for money or drugs (data not shown). Both the BFP reactors and the syphilis group were more likely than (BFP reaction) is not treated for syphilis. However, the sensitivity of specific treponemal serologic testing cannot be estabthe RPR-negative group to be HIV seropositive (89%, 81%, and 76%, respectively; P õ .01).
lished for syphilis without a reference standard for comparison. Other diagnostic tests based upon a specific immune response, The 112 BFP reactors were divided into 4 groups on the basis of their temporal pattern of syphilis serologic tests over either cell-mediated or humoral, are reported to be less sensitive for HIV-infected persons. For example, serologic testing for sequential visits. Group 1 consisted of 68 subjects (61%) with reactive RPR serologic tests that did not rise above a 1:8 dilutoxoplasmosis is 85% sensitive in patients with advanced HIV disease [13] ; HIV-infected persons are more likely to be anergic of serial syphilis serologies and immunoblot testing with recombinant T. pallidum membrane antigens to identify subjects upon skin testing with common antigens [14] . Because seronegative secondary syphilis in HIV disease has been reported [6, who probably had untreated syphilis but whose syphilis serologic test results from a single visit might not have led to 7] and because BFP reactions are more likely to occur with injection drug use and HIV infection, when the risk for syphilis treatment for syphilis. We have examined atypical syphilis serologic results in a is also high, we reasoned that some of these BFP reactions might actually represent FTA-ABS-negative syphilis. In the large cohort of injection drug users and have demonstrated that sera from a small proportion of these high-risk BFP reactors absence of a true reference standard, we used temporal patterns
